Understanding how pain and emotions are processed in the brain
Neural and Psychological Mechanisms of Pain Perception
This study is trying to see how our brain processes pain and emotions and how things like expectations and social factors can change our experience of pain in healthy volunteers.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Bethesda, Maryland) |
| Trial ID | NCT02446262 on ClinicalTrials.gov |
What this trial studies
This study investigates the neural and psychological mechanisms that influence pain perception and emotional responses. It aims to understand how expectations, attention, and social factors can modify pain experiences through a series of experiments involving healthy volunteers. Participants will undergo functional magnetic resonance imaging (fMRI) scans and complete behavioral assessments to explore the relationship between pain and other sensory experiences. The study will also examine the effects of placebo instructions and different pain-related expectations on pain perception.
Who should consider this trial
Good fit: Ideal candidates are healthy volunteers aged 18 to 50 who are fluent in English.
Not a fit: Patients with major medical or psychiatric conditions, chronic pain, or those unable to comply with study procedures may not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to improved pain management strategies by leveraging psychological factors.
How similar studies have performed: While the study explores established concepts like the placebo effect, it aims to provide novel insights into the specific neural mechanisms involved, making it a unique investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: * Healthy * Between 18 and 50 years old * Fluent in English * Able to provide written informed consent. EXCLUSION CRITERIA (all sub-studies): * Unable to comply with study procedures or follow-up visits. * Has a major medical condition or medical history that in a clinician's assessment could affect heat sensitivity, pain thresholds, or ability to comply with study procedures. This may include cardiovascular, autonomic, or neurological conditions, including stroke, blindness, deafness, a history of brain damage, or a chronic systemic disease (e.g., diabetes). * Has a current mood disorder, anxiety disorder, or substance use disorder, or has a history of psychosis, hospitalization for a mental health condition, or recurrent psychiatric episodes. * Has a medical condition that in a clinician's assessment might affect somatosensation (e.g., Raynaud s disease, peripheral neuropathy, or circulatory disorder). * Has a current chronic pain condition or has had chronic pain in the past (painful condition lasting more than six months). * Has a dermatological condition affecting the testing region such as scars, burns, or recent tattoos that might influence cutaneous sensibility. * Regular use of prescription medication that has a significant effect on pain or heat perception. Excluded medications include central-acting agents such as opiates (morphine, tramadol), antidepressants (amitriptyline, duloxetine, milnacipran), anticonvulsants (gabapentin, pregabalin), anxiolytics (barbituates, benzodiazepines), hypnotics (zolpidem, sodium oxybate), antipsychotics (valproate, lithium, olanzapine), antimigraine agents (sumatriptan, ergotamine), and muscle relaxants (cyclobenzaprine, carisoprodol). Use of analgesic medications, such as non-steroidal anti-inflammatories, salicylates, and acetaminophen, taken on an "as needed" basis is acceptable as long as the last dose taken was within 5 half-lives of testing. * Is pregnant. * NIH staff member who is a subordinate/relative/co-worker of any investigator on the protocol. EXCLUSION CRITERIA (fMRI sub-studies): * Individuals with conditions that could pose a risk relating to the safety of the fMRI procedure or pain stimulation will be excluded from the MRI portion of the protocol, but may participate in the non-fMRI sessions (with the exception of pregnant women). Such conditions include: * Those with ferromagnetic metal in the cranial cavity or eye, e.g. aneurysm clip, implanted neural stimulator, cochlear implant, ocular foreign body. * Those with an abnormality on a structural MRI. * Those with an implanted cardiac pacemaker or auto-defibrillator. * Those with an insulin pump. * Those with irremovable body piercing. * Pregnant women (based on urine test completed within 24 hours prior to scan). * Individuals who are left-handed (based on self-report or score on handedness questionnaire) will be excluded from fMRI substudies. EXCLUSION CRITERIA (placebo analgesia sub-studies): -Participation in an NIH study of analgesia, as gleaned from CRIS.
Where this trial is running
Bethesda, Maryland
- National Institutes of Health Clinical Center — Bethesda, Maryland, United States (Recruiting)
Study contacts
- Principal investigator: Lauren Y Atlas, Ph.D. — National Center for Complementary and Integrative Health (NCCIH)
- Study coordinator: Adebisi O Ayodele, C.R.N.P.
- Email: bisi.ayodele@nih.gov
- Phone: (240) 593-4226
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.